Pot for Pets: CBD-Infused Pet Products Hit the Market
Ryan Allway
July 14th, 2015
Policy, Top News
Medical marijuana has been legalized in 23 states and recreational use is permitted in four states and Washington D.C., but humans aren’t the only ones taking advantage of the cannabis plant’s potential to help relieve a wide variety of symptoms.
Biscuits, edibles, and capsules containing non-psychoactive cannabinoid compounds like cannabidiol (“CBD”) are being marketed to owners of ailing and elderly animals as a way to relieve pain and reduce inflammation. Since they do not contain any tetrahydrocannabinol (“THC”), the products don’t produce the “high” associated with marijuana and some human-focused medical and recreational cannabis edibles and others products.
Companies in California, Oregon, and Washington are making these hemp-based products, including publicly traded companies like Peak Pharmaceuticals Inc. [stockquote symbol=PKPH], Greenhouse Solutions Inc. [stockquote symbol=GRSU] and American Green Inc. [stockquote symbol=ERBB]. Since hemp is completely legal to sell in food products, following the infamous HIA v. DEA lawsuit, these companies are free to sell the products without approvals.
While these companies are permitted to sell hemp-based CBD-infused pet products, that doesn’t mean that regulators haven’t taken any action.
The U.S. Food and Drug Administration (“FDA”) took a bite out of the industry in February of 2015 when it issued several warning letters to firms that were “marketing unapproved drugs for the diagnosis, cure, mitigation, treatment, or prevention of diseases”. In addition to the inappropriate marketing messages, the regulatory agency found that many of the samples tested didn’t contain any cannabidiol (“CBD”) at all despite the marketing claims.
Many industry experts compared these warnings to similar warnings issued to nutritional supplement manufacturers back in the 1980s. Prior to that crackdown, many companies were inappropriately marketing their products to treat certain ailments and conditions, despite the lack of clinical data showing any such efficacy. The industry was ultimately forced to include labels on everything saying “these statements have not been evaluated by the FDA”.
Despite these legal hurdles, the market for hemp-based CBD-infused products for pets is unlike to disappear anytime soon. There’s a growing body of research showing that cannabinoids may be able to stimulate appetite, reduce inflammation, and lower pain levels, while the hype surrounding the human cannabis industry has certainly generated some buzz.
The pet industry already generates more than $60 billion per year in expenditures, including $23 billion on food and $15 billion on OTC medicine, according to the American Pet Products Association. Capturing just a fraction of that market could create some big opportunities for investors and entrepreneurs in the space.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Matthew Nordgren is an ambitious executive, dedicated philanthropist, and accomplished athlete who brings a unique passion to creating strategic alliances. He has breadth and depth of experience in finance, corporate development, and capital sourcing, as well as in building highly motivated teams of skilled professionals. In 2005, Mr. Nordgren received his education at the University […]
Tom Zuber is Zuber Lawler & Del Duca’s Managing Partner. He has a degree with highest honors in biomedical engineering and has advised some of the most iconic companies in the world on their patent and trademark portfolios. He is at the cutting edge of cannabis patent and trademark law. He holds degrees from Harvard University and Columbia Law […]
Cannabix Technologies Inc. is a leader in marijuana breathalyzer development for law enforcement and the workplace.
Headquartered in Lakewood, Colo., STWC Holdings is a complete ecosystem of entities and services that support the burgeoning cannabis industry.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
